Lowry SF - Search Results

1

Interleukin 1 binding to its type I, but not type II receptor, modulates the in vivo acute phase response.

Oldenburg HS, Pruitt JH, Lazarus DD, Rogy MA, Chizzonite R, Lowry SF, Moldawer LL. Oldenburg HS, et al. Among authors: lowry sf. Cytokine. 1995 Aug;7(6):510-6. doi: 10.1006/cyto.1995.0069. Cytokine. 1995. PMID: 8580366 Free article.

2

Insulin-like growth factor-1 activity is inhibited by interleukin-1 alpha, tumor necrosis factor-alpha, and interleukin-6.

Lazarus DD, Moldawer LL, Lowry SF. Lazarus DD, et al. Among authors: lowry sf. Lymphokine Cytokine Res. 1993 Aug;12(4):219-23. Lymphokine Cytokine Res. 1993. PMID: 8218594

3

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6.

Oldenburg HS, Rogy MA, Lazarus DD, Van Zee KJ, Keeler BP, Chizzonite RA, Lowry SF, Moldawer LL. Oldenburg HS, et al. Among authors: lowry sf. Eur J Immunol. 1993 Aug;23(8):1889-94. doi: 10.1002/eji.1830230824. Eur J Immunol. 1993. PMID: 8344351

4

Influence of hypercortisolemia on the acute-phase protein response to endotoxin in humans.

Rock CS, Coyle SM, Keogh CV, Lazarus DD, Hawes AS, Leskiw M, Moldawer LL, Stein TP, Lowry SF. Rock CS, et al. Among authors: lowry sf. Surgery. 1992 Aug;112(2):467-74. Surgery. 1992. PMID: 1379382

5

Interleukin 1 receptor blockade attenuates the host inflammatory response.

Gershenwald JE, Fong YM, Fahey TJ 3rd, Calvano SE, Chizzonite R, Kilian PL, Lowry SF, Moldawer LL. Gershenwald JE, et al. Among authors: lowry sf. Proc Natl Acad Sci U S A. 1990 Jul;87(13):4966-70. doi: 10.1073/pnas.87.13.4966. Proc Natl Acad Sci U S A. 1990. PMID: 1695006 Free PMC article.

6

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia.

Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, et al. Fong Y, et al. Among authors: lowry sf. J Exp Med. 1989 Nov 1;170(5):1627-33. doi: 10.1084/jem.170.5.1627. J Exp Med. 1989. PMID: 2809510 Free PMC article.

7

Endogenous IL-10 protects mice from death during septic peritonitis.

van der Poll T, Marchant A, Buurman WA, Berman L, Keogh CV, Lazarus DD, Nguyen L, Goldman M, Moldawer LL, Lowry SF. van der Poll T, et al. Among authors: lowry sf. J Immunol. 1995 Dec 1;155(11):5397-401. J Immunol. 1995. PMID: 7594556

8

Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis.

van der Poll T, Fischer E, Coyle SM, Van Zee KJ, Pribble JP, Stiles DM, Barie PS, Buurman WA, Moldawer LL, Lowry SF. van der Poll T, et al. Among authors: lowry sf. J Infect Dis. 1995 Aug;172(2):577-80. doi: 10.1093/infdis/172.2.577. J Infect Dis. 1995. PMID: 7622910 Clinical Trial.

9

Interleukin-1 receptor blockade does not affect endotoxin-induced changes in plasma thyroid hormone and thyrotropin concentrations in man.

van der Poll T, Van Zee KJ, Endert E, Coyle SM, Stiles DM, Pribble JP, Catalano MA, Moldawer LL, Lowry SF. van der Poll T, et al. Among authors: lowry sf. J Clin Endocrinol Metab. 1995 Apr;80(4):1341-6. doi: 10.1210/jcem.80.4.7714108. J Clin Endocrinol Metab. 1995. PMID: 7714108 Clinical Trial.

10

Influence of IL-1 receptor blockade on the human response to endotoxemia.

Van Zee KJ, Coyle SM, Calvano SE, Oldenburg HS, Stiles DM, Pribble J, Catalano M, Moldawer LL, Lowry SF. Van Zee KJ, et al. Among authors: lowry sf. J Immunol. 1995 Feb 1;154(3):1499-507. J Immunol. 1995. PMID: 7822813 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters